Hydrogels for Cardiac Tissue Repair and Regeneration
Article Sidebar
Main Article Content
Abstract
The main cause of death in the world continues to be cardiovascular disease, which affects annually over 900,000 people and in the entire word approximately 50% of the people suffering myocardial infarction (MI) die within 5 years. MI causes a number of cardiac pathologies like hypertension, blocked coronary arteries and valvular heart diseases resulting ischemic cardiac injury. In the last years, cardiac tissue engineering has made considerable progress, because this progress have been made towards developing injectable hydrogels for the purpose of cardiac repair and/or regeneration. This study aims to provide an updated survey of the major progress in the flied of injectable cardiac tissue engineering, including biomaterials (natural, synthetic or hybrid hydrogels), their advantages or disadvantages and the main seeding cell sources. Also, this review focuses on the progress made in the field of hydrogels for cardiac tissue repair and/or regeneration for MI over the last years.
Downloads
Article Details
Copyright (c) 2017 Grigore ME.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Ahmadi A (2014) Application of Collagen Matrices for Enhancing Cardiac Regeneration. Université d'Ottawa/University of Ottawa. Link: https://goo.gl/T4haKt
Ungerleider JL, Johnson TD, Rao N, Christman KL (2015) Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle. Methods 84: 53-59. Link: https://goo.gl/3ag22I
Radhakrishnan J, Krishnan UM1, Sethuraman S (2014) Hydrogel based injectable scaffolds for cardiac tissue regeneration. Biotechnol Adv 32: 449-461. Link: https://goo.gl/dOiiYw
Wang H, Zhou J, Liu Z, Wang C (2010) Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med 14: 1044-1055. Link: https://goo.gl/nDCFSC
Christman KL, Lee RJ (2006) Biomaterials for Treating Myocardial Infarctions. J Am Coll Cardiol 48: 907-913. Link: https://goo.gl/qRRwti
Tous E, Purcell B, Ifkovits JL, Burdick JA (2011) Injectable acellular hydrogels for cardiac repair. J Cardiovasc Transl Res 4: 528-542. Link: https://goo.gl/KAYgaJ
Hasan A, Khattab A, Islam MA, Hweij KA, Zeitouny J, et al. (2015) Injectable hydrogels for cardiac tissue repair after myocardial infarction. Adv Sci (Weinh) 2. Link: https://goo.gl/Kmcc1a
Fang R, Qiao S, Liu Y, Meng Q, Chen X, Song B, et al. (2015) Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts. Int J Nanomedicine 10: 4691-4703. Link: https://goo.gl/1UepCg
Tan H, Marra KG (2010) Injectable, biodegradable hydrogels for tissue engineering applications. Materials 3: 1746-1767. Link: https://goo.gl/eV3WnC
Tian S, Liu Q, Gnatovskiy L, X Ma P, Wang Z (2015) Heart regeneration with embryonic cardiac progenitor cells and cardiac tissue engineering. J Stem Cell Transplant Biol 1: 104. Link: https://goo.gl/1sFAVg
dos Santos CCL, Farias IAP, dos Reis Albuquerque AJ, de Freitas e Silva PM, da Costa One GM, et al, (2014) Antimicrobial activity of nano cerium oxide (IV)(CeO2) against Streptococcus mutans. BMC Proc 8: 48. Link: https://goo.gl/mu8CV7
Reis L (2014) 3 - Injectable biomaterials for cardiac regeneration and repair, in Cardiac Regeneration and Repair. Woodhead Publishing 49-81.
Camci-Unal G, Annabi N, Dokmeci MR, Liao R, Khademhosseini A (2014) Hydrogels for cardiac tissue engineering. NPG Asia Mater 6: e99. Link: https://goo.gl/xiBsdx
Li Z, Guan J (2011) Hydrogels for cardiac tissue engineering. Polymers 3: 740-761. Link: https://goo.gl/HwVtNu
Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Marsano A, et al. (2009) Challenges in cardiac tissue engineering. Tissue Eng Part B Rev 16: 169-187. Link: https://goo.gl/zwnDdY
Li RK, Weisel RD (2014) Cardiac Regeneration and Repair: Biomaterials and Tissue Engineering. Elsevier. Link: https://goo.gl/or23Tc
Ye Z (2011) Myocardial regeneration: Roles of stem cells and hydrogels. Advanced drug delivery reviews 63: 688-697. Link: https://goo.gl/NoFaSX
Wu J, Zeng F, Weisel RD, Li RK (2009) Stem cells for cardiac regeneration by cell therapy and myocardial tissue engineering, Adv Biochem Eng Biotechnol 107-128. Link: https://goo.gl/SpBnhK
Rodríguez-Vázquez M, Vega-Ruiz B, Ramos-Zúñiga R, Saldaña-Koppel DA, Quiñones-Olvera LF (2015) Chitosan and its potential use as a scaffold for tissue engineering in regenerative medicine. BioMed research international 2015. Link: https://goo.gl/z0Cexc
Lekka M, Laidler P, Ignacak J, Łabedz M, Lekki J, et al. (2001) The effect of chitosan on stiffness and glycolytic activity of human bladder cells. Biochim Biophys Acta 1540: 127-136. Link: https://goo.gl/PzLPxb
Menaa F, Menaa A, Menaa B (2011) Hyaluronic Acid and Derivatives for Tissue Engineering. Journal of Biotechnology & Biomaterials 2013. Link: https://goo.gl/IbTh6r
Shen YI, Abaci HE1, Krupsi Y1, Weng LC1, Burdick JA, et al. (2014) Hyaluronic acid hydrogel stiffness and oxygen tension affect cancer cell fate and endothelial sprouting. Biomater Sci 2: 655-665. Link: https://goo.gl/ZlTHgf
Lee KY, Mooney DJ (2012) Alginate: properties and biomedical applications. Progress in polymer science 37: 106-126. Link: https://goo.gl/F1EKxx
Ikada Y (2011) Tissue engineering: fundamentals and applications. 8: Academic Press. Link: https://goo.gl/yry6sg
Trandafir V, Albu MG (2007) Bioproduse pe bază de colagen. Ars Docendi.
Suuronen EJ, Veinot JP, Wong S, Kapila V, Price J, et al. (2006) Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 114: I-138-I-144. Link: https://goo.gl/S0hVyJ
Hastings CL, Roched ET, Ruiz-Hernandeza E, Schenke-Laylandf K, Walsh CJ, et al. (2015) Drug and cell delivery for cardiac regeneration. Advanced drug delivery reviews 84: 85-106. Link: https://goo.gl/TTq7Qd
Chiu LL, Reis LA, Momen A, Radisic M (2012) Controlled release of thymosin β4 from injected collagen–chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction. Regen Med 7: 523-533. Link: https://goo.gl/yXWM3P
Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, et al. (2003) Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 18: 93-99. Link: https://goo.gl/nE5Wyi
Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, et al. (2003) Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 24: 105-112. Link: https://goo.gl/WnSIyp
Liu Y, Sun L, Huan Y, Zhao H, Deng J (2006) Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur J Cardiothorac Surg 30: 103-107. Link: https://goo.gl/HmfU1B
Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, et al. (2002) Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124: 50-56. Link: https://goo.gl/SjACjP
Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, et al. (2000) Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106: 1511-1519. Link: https://goo.gl/MdpKwb
Kobayashi H, Minatoguchi S, Yasuda S, Bao N, Kawamura I, et al. (2008) Post-infarct treatment with an erythropoietin–gelatin hydrogel drug delivery system for cardiac repair. Cardiovasc Res 79: 611-620. Link: https://goo.gl/bsdSbA
Johnson TD, Christman K (2013) Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv 10: 59-72. Link: https://goo.gl/JI3kn1
Yoon SJ, Hong S, Fang YH, Song M, Son KH, et al. (2014) Differential regeneration of myocardial infarction depending on the progression of disease and the composition of biomimetic hydrogel. J Biosci Bioeng 118: 461-468. Link: https://goo.gl/vFlaCz
Nair LS (2015) Injectable Hydrogels for Regenerative Engineering. World Scientific. Link: https://goo.gl/xU5xXW
Yoon SJ, Fang YH, Lim CH, Kim BS, Son HS, et al. (2009) Regeneration of ischemic heart using hyaluronic acid‐based injectable hydrogel. J Biomed Mater Res B Appl Biomater 91: 163-171. Link: https://goo.gl/h34DI6
Ifkovits JL, Tous E, Minakawa M, Morita M, Robb JD, et al. (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A 107: 11507-11512. Link: https://goo.gl/P864sl
Shoichet MS (2009) Polymer scaffolds for biomaterials applications. Macromolecules 43: 581-591. Link: https://goo.gl/8GZO1B
Shaikh FM, Callanan A, Kavanagh EG, Burke PE, Grace PA, et al. (2008) Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188: 333-346. Link: https://goo.gl/yDPajQ
Li Y, Meng H, Liu Y, Lee BP (2015) Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering. The Scientific World Journal 2015. Link: https://goo.gl/1a4eBE
Nelson DM, Ma Z, Fujimoto KL, Hashizume R, Wagner WR (2011) Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater 7: 1-15. Link: https://goo.gl/anKRSl
Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ (2004) Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 10: 403-409. Link: https://goo.gl/CPTwqw
Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, et al. (2004) Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44: 654-660. Link: https://goo.gl/zLJSn4
Liu J, Hu Q, Wang Z, Xu C, Wang X, et al. (2004) Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol 287: H501-H511. Link: https://goo.gl/ya7GtF
Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK , (2005) Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26: 319-326. Link: https://goo.gl/HfIkSi
Madden LR, Mortisenb DJ, Sussmana EM, Duprasc SK, Fugate JA. et al. (2010) Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proceedings of the National Academy of Sciences 107: 15211-15216. https://goo.gl/GVAU37
Van Vlierberghe S, Dubruel P, Schacht E (2011) Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review. Biomacromolecules 12: 1387-1408. Link: https://goo.gl/tV15se
Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, et al. (2008) Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117: 1388-1396. Link: https://goo.gl/OqM8ew
Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, et al. (2002) Bioengineered cardiac grafts a new approach to repair the infarcted myocardium? Circulation 102: Iii-56-Iii-61. Link: https://goo.gl/oMsvjv
Koh CJ, Atala A (2004) Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 15: 1113-1125. Link: https://goo.gl/gtqrN9
Lee KY, Rowley JA, Eiselt P, Moy EMBouhadir KH, et al. (2000) Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 33: 4291-4294. Link: https://goo.gl/UCYhOK
Leor J, Tuvia S, Guetta V, Manczur F, Castel D, et al. (2009) Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 54: 1014-1023. Link: https://goo.gl/D5pFWg
Leor J (2004) A novel injectable alginate scaffold promotes angiogenesis and preserves left ventricular geometry and function after extensive myocardial infarction in rat. in Circulation. Lippincott Williams & Wilkins 530 Walnut St, Philadelphia, Pa 19106-3621 USA.
Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, et al. (2010) A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A 16: 3099-3109. Link: https://goo.gl/Y0NJwT
Kim IY, Seo SJ, Moon HS, Yoo MK, Park IY, et al. (2008) Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 26: 1-21. Link: https://goo.gl/FpvR2j
Wang L, Stegemann JP (2010) Thermogelling chitosan and collagen composite hydrogels initiated with β-glycerophosphate for bone tissue engineering. Biomaterials 31: 3976-3985. Link: https://goo.gl/87W98J
Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, et al. (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21: 2155-2161. Link: https://goo.gl/XX9w4v
Yagi K, Michibayashi N, Kurikawa N, Nakashima Y, Mizoguchi T, et al. (1997) Effectiveness of fructose-modified chitosan as a scaffold for hepatocyte attachment. Biol Pharm Bull 20: 1290-1294. Link: https://goo.gl/uggCFC
Wang H, Shi J, Wang Y, Yin Y, Wang L, et al. (2014) Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Biomaterials 35: 3986-3998. Link: https://goo.gl/ffmT0K
Fujita M, Ishihara M, Morimoto Y, Simizu M, Saito Y, et al. (2005) Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J Surg Res 126: 27-33. Link: https://goo.gl/07ES4M
Lu WN, Lü SH, Wang HB, Li DX, Duan CM, et al. (2008) Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A 15: 1437-1447. Link: https://goo.gl/1wLc6r
Fiamingo A, Montembault A, Boitard S, Naemetalla H, Agbulut O, et al. (2016) Chitosan Hydrogels for the Regeneration of Infarcted Myocardium: Preparation, Physicochemical Characterization, and Biological Evaluation. Biomacromolecules 17: 1662-1672. Link: https://goo.gl/q0U16L
Lutolf M, Hubbell J (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature biotechnology 23: 47-55. Link: https://goo.gl/N99vg8
Li Y, Rodrigues J, Tomás H (2012) Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem Soc Rev 41: 2193-2221. Link: https://goo.gl/igpwSi
Singelyn JM, Christman KL (2010) Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res 3: 478-486. Link: https://goo.gl/mQ6GpX
Dobner S, Bezuidenhout D, Govender P, Zilla P, Davies N (2009) A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling. J Card Fail 15: 629-636. Link: https://goo.gl/n8C2yL
Gaetani RJ Ungerleider, Christman KL (2016) Chapter 25 - Acellular Injectable Biomaterials for Treating Cardiovascular Disease A2 - Perin, Emerson C, in Stem Cell and Gene Therapy for Cardiovascular Disease, LW Miller, DA Taylor, J.T. Willerson, Editors. 2016, Academic Press: Boston. 309-325.
Wang T, Jiang XJ, Tang QZ, Li XY, Lin T, et al. (2009) Bone marrow stem cells implantation with α-cyclodextrin/MPEG–PCL–MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater 5: 2939-2944. Link: https://goo.gl/1D87Aj
Klouda L, Mikos AG (2008) Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68: 34-45. Link: https://goo.gl/0mqlH5
Cohen S, Leor J (2004) Rebuilding broken hearts. Scientific American 291: 44-51. Link: https://goo.gl/uosKT3
Fujimoto KL, Ma Z, Nelson DM, Hashizume R, Guan J, et al. (2009) Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 30: 4357-4368. Link: https://goo.gl/AbLCa3
Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, et al. (2005) Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 80: 1586-1595. Link: https://goo.gl/z8uFEB
Seif-Naraghi SB, Horn D, Schup-Magoffin PJ, Christman KL (2012) Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta biomaterialia 8: 3695-3703. Link: https://goo.gl/Sf7jwd
Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA (2009) Hydrogels in regenerative medicine. Adv Mater 21: 3307-3329. Link: https://goo.gl/4MrDfv
Lee KY, Mooney DJ (2001) Hydrogels for tissue engineering. Chem Rev 101: 1869-1879. Link: https://goo.gl/HtAwS4
Millon LE, Mohammadi H, Wan WK (2006) Anisotropic polyvinyl alcohol hydrogel for cardiovascular applications. J Biomed Mater Res B Appl Biomater 79: 305-311. Link: https://goo.gl/NnAoV7
Janani A, Skylab RS (2014) Injectable Hydrogel for Cardiac tissue Engineering. International Journal of ChemTech Research 6: 2233-2236. Link: https://goo.gl/289VzY
Nikkhah M (2015) Gold nanorod-incorporated Gelatin-based Hybrid Hydrogels for Cardiac Tissue Engineering. Link: https://goo.gl/rW8gNd
Mihardja SS, Sievers RE, Lee RJ (2008) The effect of polypyrrole on arteriogenesis in an acute rat infarct model. Biomaterials 29: 4205-4210. Link: https://goo.gl/NGTCzO
Pok S, Myers JD, Madihally SV, Jacot JG (2013) A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering. Acta biomaterialia 9: 5630-5642. Link: https://goo.gl/gZlxbZ
Paul A (2015) Nanocomposite hydrogels: an emerging biomimetic platform for myocardial therapy and tissue engineering. Nanomedicine 10: 1371-1374. Link: https://goo.gl/6jlSrR
Paul A, Hasan A, Kindi HA, Gaharwar AK, Rao VT, et al. (2014) Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS nano 8: 8050-8062. Link: https://goo.gl/Xo86YC
rishna KA (2011) Myocardial infarction and stem cells. Journal of Pharmacy and Bioallied Sciences 3: 182-188. Link:
Smits AM, van Vliet P, Hassink RJ, Goumans MJ, Doevendans PA (2005) The role of stem cells in cardiac regeneration. J Cell Mol Med 9: 25-36. Link: https://goo.gl/hl2Llx
Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A (2009) Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc 84: 876-892. Link: https://goo.gl/Q1UiOi
Hou J, Wang L, Jiang J, Zhou C, Guo T, et al. (2013) Cardiac stem cells and their roles in myocardial infarction. Stem Cell Rev 9: 326-338. Link: https://goo.gl/F8e31m
Bara JJ, Richards RG, Alini M, Stoddart MJ (2014) Concise Review: Bone Marrow‐Derived Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for Basic Research and the Clinic. Stem cells 32: 1713-1723. Link: https://goo.gl/h3J7va
Murry CE, Field LJ, Menasché P (2005) Cell-based cardiac repair reflections at the 10-year point. Circulation 112: 3174-3183. Link: https://goo.gl/CtxoJn
Kudo M, Wang Y, Wani MA, Xu M, Ayub A, et al. (2003) Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 35: 1113-1119. Link: https://goo.gl/smOQRJ
Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA (2002) The post‐natal heart contains a myocardial stem cell population. FEBS lett 530: 239-243. Link: https://goo.gl/XKn63z
Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776. Link: https://goo.gl/Kbtsc2
Bollini S, Smart N, Riley PR (2011) Resident cardiac progenitor cells: at the heart of regeneration. J Mol Cell Cardiol 50: 296-303. Link: https://goo.gl/wGUhjI